NASDAQ:DOMH Dominari (DOMH) Stock Price, News & Analysis $6.35 -0.02 (-0.31%) As of 09:47 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Dominari Stock (NASDAQ:DOMH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Dominari alerts:Sign Up Key Stats Today's Range$6.29▼$6.4350-Day Range$4.50▼$7.4252-Week Range$0.83▼$13.58Volume13,843 shsAverage Volume795,146 shsMarket Capitalization$98.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York. Read More Dominari Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks13th Percentile Overall ScoreDOMH MarketRank™: Dominari scored higher than 13% of companies evaluated by MarketBeat, and ranked 930th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Dominari.Read more about Dominari's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Dominari is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dominari is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDominari has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Dominari's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.57% of the float of Dominari has been sold short.Short Interest Ratio / Days to CoverDominari has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dominari has recently increased by 12.94%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDominari does not currently pay a dividend.Dividend GrowthDominari does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted12.57% of the float of Dominari has been sold short.Short Interest Ratio / Days to CoverDominari has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dominari has recently increased by 12.94%, indicating that investor sentiment is decreasing significantly. News and Social Media3.2 / 5News Sentiment0.67 News SentimentDominari has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Dominari this week, compared to 1 article on an average week.Search Interest3 people have searched for DOMH on MarketBeat in the last 30 days. MarketBeat Follows5 people have added Dominari to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Dominari insiders have not sold or bought any company stock.Percentage Held by Insiders32.98% of the stock of Dominari is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.48% of the stock of Dominari is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Dominari's insider trading history. Receive DOMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOMH Stock News HeadlinesTrump brothers-backed Dominari Holdings cleared to lead IPOs on NYSEOctober 9 at 1:54 PM | msn.comDominari Board Member Steps Down to Become Interim CFOSeptember 24, 2025 | marketwatch.comToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a single day. AMD jumped over 6%. But what if you didn’t need to chase the news?October 10 at 2:00 AM | Timothy Sykes (Ad)Dominari Holdings Announces Board Member Tim Ledwick to Assume Role of Interim Chief Financial OfficerSeptember 23, 2025 | prnewswire.comDominari Holdings Appoints New Chief Financial OfficerSeptember 22, 2025 | tipranks.comDominari Holdings Appoints Brian Parsley as DirectorSeptember 10, 2025 | tipranks.comDominari Securities Appoints Communications and Growth Strategist Brian Parsley to BoardSeptember 10, 2025 | prnewswire.comDominari Holdings Applauds American Bitcoin's Nasdaq Debut; Highlights Strategic StakeSeptember 9, 2025 | prnewswire.comSee More Headlines DOMH Stock Analysis - Frequently Asked Questions How have DOMH shares performed this year? Dominari's stock was trading at $0.9844 at the start of the year. Since then, DOMH stock has increased by 547.1% and is now trading at $6.37. How were Dominari's earnings last quarter? Dominari Holdings Inc. (NASDAQ:DOMH) released its quarterly earnings data on Monday, August, 11th. The company reported ($1.02) earnings per share (EPS) for the quarter. The firm earned $34.10 million during the quarter. Dominari had a negative trailing twelve-month return on equity of 94.32% and a negative net margin of 36.01%. How do I buy shares of Dominari? Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Dominari own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dominari investors own include Avino Silver & Gold Mines (ASM), Crescent Point Energy (CPG), Infinera (INFN), Kroger (KR), KraneShares CSI China Internet ETF (KWEB) and MSP Recovery (LIFW). Company Calendar Last Earnings8/11/2025Record date for 9/26 Dividend9/03/2025Ex-Dividend for 9/26 Dividend9/03/2025Dividend Payable9/26/2025Today10/10/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryBiotechnology Current SymbolNASDAQ:DOMH Previous SymbolNASDAQ:DOMH CIK12239 WebN/A Phone(112) 745-1374Fax703-992-9348Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.70 million Net Margins-36.01% Pretax Margin-34.03% Return on Equity-94.32% Return on Assets-78.21% Debt Debt-to-Equity RatioN/A Current Ratio3.65 Quick Ratio3.65 Sales & Book Value Annual Sales$18.15 million Price / Sales5.45 Cash FlowN/A Price / Cash FlowN/A Book Value$5.71 per share Price / Book1.12Miscellaneous Outstanding Shares15,540,000Free Float10,418,000Market Cap$98.99 million OptionableNot Optionable Beta0.75 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:DOMH) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dominari Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dominari With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.